HK1055444A1 - Mutant muscle-specific enhancers - Google Patents

Mutant muscle-specific enhancers

Info

Publication number
HK1055444A1
HK1055444A1 HK03107673A HK03107673A HK1055444A1 HK 1055444 A1 HK1055444 A1 HK 1055444A1 HK 03107673 A HK03107673 A HK 03107673A HK 03107673 A HK03107673 A HK 03107673A HK 1055444 A1 HK1055444 A1 HK 1055444A1
Authority
HK
Hong Kong
Prior art keywords
muscle
specific enhancers
expression systems
present
mutant muscle
Prior art date
Application number
HK03107673A
Other languages
English (en)
Inventor
James S Chamberlain
Stephen D Hauschka
Original Assignee
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Michigan filed Critical Univ Michigan
Publication of HK1055444A1 publication Critical patent/HK1055444A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1223—Phosphotransferases with a nitrogenous group as acceptor (2.7.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK03107673A 2000-07-14 2003-10-23 Mutant muscle-specific enhancers HK1055444A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21843600P 2000-07-14 2000-07-14
PCT/US2001/022092 WO2002006495A2 (en) 2000-07-14 2001-07-13 Mutant muscle-specific enhancers

Publications (1)

Publication Number Publication Date
HK1055444A1 true HK1055444A1 (en) 2004-01-09

Family

ID=22815112

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03107673A HK1055444A1 (en) 2000-07-14 2003-10-23 Mutant muscle-specific enhancers

Country Status (7)

Country Link
US (1) US20110097761A1 (xx)
EP (1) EP1303617B1 (xx)
AT (1) ATE373095T1 (xx)
AU (1) AU2294102A (xx)
DE (1) DE60130465T2 (xx)
HK (1) HK1055444A1 (xx)
WO (1) WO2002006495A2 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2778945A1 (en) * 2009-10-29 2011-05-05 Vib Vzw Cardiac-specific nucleic acid regulatory elements and methods and use thereof
CN104031919B (zh) * 2014-03-24 2017-04-19 内蒙古大学 一种能够在哺乳动物肌肉组织中特异启动基因表达的启动子序列及其应用
MA45477A (fr) 2016-04-15 2019-02-20 Res Inst Nationwide Childrens Hospital Administration à vecteurs de virus adéno-associé de microarn-29 et micro-dystrophine pour traiter la dystrophie musculaire
CA2971303A1 (en) 2016-06-21 2017-12-21 Bamboo Therapeutics, Inc. Optimized mini-dystrophin genes and expression cassettes and their use
US11534501B2 (en) 2017-10-18 2022-12-27 Research Institute At Nationwide Children's Hospital Adeno-associated virus vector delivery of muscle specific micro-dystrophin to treat muscular dystrophy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994132A (en) * 1996-10-23 1999-11-30 University Of Michigan Adenovirus vectors

Also Published As

Publication number Publication date
ATE373095T1 (de) 2007-09-15
EP1303617A2 (en) 2003-04-23
DE60130465T2 (de) 2008-06-12
WO2002006495A3 (en) 2002-07-04
WO2002006495A2 (en) 2002-01-24
EP1303617B1 (en) 2007-09-12
DE60130465D1 (de) 2007-10-25
AU2294102A (en) 2002-01-30
US20110097761A1 (en) 2011-04-28

Similar Documents

Publication Publication Date Title
WO2003080807A3 (en) Compositions and methods for suppressing eukaryotic gene expression
NZ504185A (en) Expression of endogenous genes by non-homologous recombination of a vector construct with cellular DNA
EP2267138A3 (en) Methods and means for obtaining modified phenotypes
AU6672601A (en) Cold sensitive mutant dna polymerases
MXPA03000634A (es) Metodos para el reemplazo, el desplazamiento y acumulacion de adn en genomas eucarioticos.
DE69636866D1 (en) Reverse "two-hybrid"-systeme
AP1678A (en) Novel modified nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems.
MXPA06000092A (es) Transformacion de cloroplasto de la lenteja de agua.
SG149003A1 (en) Gene expression technique
DE69808743D1 (en) Netrinrezeptoren
IL140439A0 (en) Polyketides, their preparation and materials for use therein
HK1055444A1 (en) Mutant muscle-specific enhancers
EP0763205A4 (en) NUCLEIC ACID SEQUENCES REGULATING THE EXPRESSION OF LUNG SPECIFIC GENES
WO2003066867A3 (en) Genetically engineered phic31-integrase genes
CA2487290A1 (en) Ehd1 gene promoting plant flowering and utilization thereof
WO2002006462A3 (en) Methylated nucleotide regulation of upa gene expression
WO2004029233A3 (en) Mutant recombinases
AU7645400A (en) Polypeptides having glucanotransferase activity and nucleic acids encoding same
WO2002068669A3 (de) Episomale vektoren enthaltend matrix-anheftungsregionen zur zellspezifischen genexpression
WO1999048486A3 (en) Plant cell cyclin genes
HUP0400915A2 (hu) Növényi reprodukciós proteinek
AU4395599A (en) (-)-strand rna virus vector for nerve cell
WO2004099385A3 (en) Telomere elongation
NZ501962A (en) Vertebrate telomerase genes and proteins and uses thereof
EP1338652A3 (en) Plant cell cyclin genes

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20210712